General, upper GI and advanced laparoscopic surgery
Mr Andrew R DaviesBSc (Hons) MBChB MSc MD FRCS
T : (0203) 7635933

Archive for the ‘News’ Category

Comprehensive Upper GI service available at London Bridge Hospital

December 22nd, 2014 by admin in News No Comments »

http://www.londonbridgehospital.com/LBH/treatments-specialties/upper-gastrointestinal-surgery/

Oesophageal cancer awareness campaign

October 27th, 2014 by admin in News No Comments »

http://www.londonbridgehospital.com/LBH/media-centre/general-news/city-of-london-medical-centre-backs-campaign-to-save-lives-through-earlier-diagnosis-of-oesophageal-cancer/

New one-stop clinic in the City of London

October 24th, 2014 by admin in News No Comments »

http://www.citymedicalcentre.co.uk/services/one-stop-surgical-clinic/

​Surveillance endoscopy at five or more years after cardiomyotomy for achalasia

October 13th, 2014 by admin in News No Comments »

​OBJECTIVE: ​​To perform long-term histopathological and clinical assessment of patients who have previously undergone cardiomyotomy for achalasia. BACKGROUND: There are few studies on long-term outcome for patients treated by cardiomyotomy for achalasia. Recent publications suggest that these patients may be at high risk of both squamous cell carcinoma and adenocarcinoma of the esophagus. METHODS: All […]

GP Magazine Health Matters Winter 2013 Issue 13

October 1st, 2014 by admin in News No Comments »

Consultant General Surgeon, Mr James Gossage, recently performed a Laparoscopic Bilateral Inguinal Hernia Repair procedure on one of his patients, a 54-year-old male.

Tumor Downstaging After Neoadjuvant Chemotherapy Strongly Predicts Improved Outcome After Surgery in Esophageal and Esophagogastric Junction Cancer

August 4th, 2014 by admin in News No Comments »

In a European analysis reported in the Journal of Clinical Oncology, Davies et al found that pathologic tumor downstaging after neoadjuvant chemotherapy was the strongest independent predictor of overall survival in patients undergoing surgery for esophageal and esophagogastric junction adenocarcinoma. Compared with no response, downstaging was also associated with significantly lower rates of local and […]

Stage after neoadjuvant chemo predicts esophageal cancer outcome

July 31st, 2014 by admin in News No Comments »

NEW YORK (Reuters Health) – Tumor stage after neoadjuvant chemotherapy is more important than the initial tumor stage in gauging prognosis after surgery for adenocarcinoma of the esophagus and esophagogastric junction, according to a study from the United Kingdom. “This study indicates that the established local downstaging effect of neoadjuvant chemotherapy in resectable esophageal adenocarcinoma […]

Stage esophageal cancer after neoadjuvant chemo

July 28th, 2014 by admin in News No Comments »

Among patients with resectable esophageal adenocarcinoma, tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor stage at…

Stage esophageal cancer after neoadjuvant chemo

July 28th, 2014 by admin in News No Comments »

“No previous study has been able to quantify the local and systemic downstaging effects of systemic therapy in this manner and combine it with robust long-term follow-up data,” they noted. This study was supported by the Swedish Research Council, the Swedish Cancer Society, and the National Institute of Health Research, Royal Marsden /Institute of Cancer […]

Stage esophageal cancer after neoadjuvant chemo

July 28th, 2014 by admin in News No Comments »

Among patients with resectable esophageal adenocarcinoma, tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor stage at presentation, according to a report published online July 28 in Journal of Clinical Oncology. Researchers analyzed data regarding 584 consecutive resections for adenocarcinoma of the esophagus or esophagogastric […]